A Metabolomics Approach to Pharmacotherapy Personalization
AbstractThe optimization of drug therapy according to the personal characteristics of patients is a perspective direction in modern medicine. One of the possible ways to achieve such personalization is through the application of “omics” technologies, including current, promising metabolomics methods. This review demonstrates that the analysis of pre-dose metabolite biofluid profiles allows clinicians to predict the effectiveness of a selected drug treatment for a given individual. In the review, it is also shown that the monitoring of post-dose metabolite profiles could allow clinicians to evaluate drug efficiency, the reaction of the host to the treatment, and the outcome of the therapy. A comparative description of pharmacotherapy personalization (pharmacogenomics, pharmacoproteomics, and therapeutic drug monitoring) and personalization based on the analysis of metabolite profiles for biofluids (pharmacometabolomics) is also provided. View Full-Text
Share & Cite This Article
Balashova, E.E.; Maslov, D.L.; Lokhov, P.G. A Metabolomics Approach to Pharmacotherapy Personalization. J. Pers. Med. 2018, 8, 28.
Balashova EE, Maslov DL, Lokhov PG. A Metabolomics Approach to Pharmacotherapy Personalization. Journal of Personalized Medicine. 2018; 8(3):28.Chicago/Turabian Style
Balashova, Elena E.; Maslov, Dmitry L.; Lokhov, Petr G. 2018. "A Metabolomics Approach to Pharmacotherapy Personalization." J. Pers. Med. 8, no. 3: 28.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.